- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
121
Companies with a Value score of at least 3, ordered by Value score
121 companies
Genscript Biotech
Market Cap: HK$25.5b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$11.64
7D
-13.3%
1Y
-31.0%
CanSino Biologics
Market Cap: HK$9.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$23.14
7D
-7.5%
1Y
-35.5%
Consun Pharmaceutical Group
Market Cap: HK$11.7b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$13.91
7D
-2.9%
1Y
21.4%
CanSino Biologics
Market Cap: HK$9.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$23.14
7D
-7.5%
1Y
-35.5%
United Laboratories International Holdings
Market Cap: HK$16.7b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$8.46
7D
-4.4%
1Y
-47.1%
Genscript Biotech
Market Cap: HK$25.5b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$11.64
7D
-13.3%
1Y
-31.0%
United Laboratories International Holdings
Market Cap: HK$16.7b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$8.46
7D
-4.4%
1Y
-47.1%
Genscript Biotech
Market Cap: HK$25.5b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$11.64
7D
-13.3%
1Y
-31.0%
CanSino Biologics
Market Cap: HK$9.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$23.14
7D
-7.5%
1Y
-35.5%
United Laboratories International Holdings
Market Cap: HK$16.7b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$8.46
7D
-4.4%
1Y
-47.1%
China Resources Pharmaceutical Group
Market Cap: HK$30.7b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.89
7D
3.8%
1Y
-8.4%
China Resources Pharmaceutical Group
Market Cap: HK$30.7b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.89
7D
3.8%
1Y
-8.4%
China Resources Pharmaceutical Group
Market Cap: HK$30.7b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.89
7D
3.8%
1Y
-8.4%
Shanghai Junshi Biosciences
Market Cap: HK$30.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.
1877
HK$16.60
7D
-8.3%
1Y
-34.9%
Duality Biotherapeutics
Market Cap: HK$16.0b
A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$176.50
7D
-11.8%
1Y
n/a
Grand Pharmaceutical Group
Market Cap: HK$17.9b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.10
7D
-1.7%
1Y
-44.9%
China Traditional Chinese Medicine Holdings
Market Cap: HK$7.6b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.50
7D
-5.1%
1Y
-33.9%
Consun Pharmaceutical Group
Market Cap: HK$11.7b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$13.91
7D
-2.9%
1Y
n/a
China Shineway Pharmaceutical Group
Market Cap: HK$6.4b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.47
7D
-1.7%
1Y
8.6%
Shanghai Junshi Biosciences
Market Cap: HK$30.5b
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.
1877
HK$16.60
7D
-8.3%
1Y
-34.9%
China Shineway Pharmaceutical Group
Market Cap: HK$6.4b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$8.47
7D
-1.7%
1Y
8.6%
3SBio
Market Cap: HK$41.2b
An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.
1530
HK$16.48
7D
0.7%
1Y
-28.3%
Luye Pharma Group
Market Cap: HK$7.5b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$1.89
7D
-12.9%
1Y
-45.8%
InnoCare Pharma
Market Cap: HK$21.3b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$10.39
7D
-5.4%
1Y
-19.8%
WuXi AppTec
Market Cap: HK$293.1b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
2359
HK$120.40
7D
-4.4%
1Y
60.6%
China Traditional Chinese Medicine Holdings
Market Cap: HK$7.6b
China Traditional Chinese Medicine Holdings Co.
570
HK$1.50
7D
-5.1%
1Y
-33.9%
Luye Pharma Group
Market Cap: HK$7.5b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$1.89
7D
-12.9%
1Y
-45.8%
Essex Bio-Technology
Market Cap: HK$1.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.67
7D
-5.0%
1Y
-47.4%
Duality Biotherapeutics
Market Cap: HK$16.0b
A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$176.50
7D
-11.8%
1Y
-34.5%
JW (Cayman) Therapeutics
Market Cap: HK$718.4m
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$1.77
7D
-8.3%
1Y
-21.3%
Everest Medicines
Market Cap: HK$9.7b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$27.50
7D
-3.9%
1Y
-49.7%
Grand Pharmaceutical Group
Market Cap: HK$17.9b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$5.10
7D
-1.7%
1Y
-44.9%
Consun Pharmaceutical Group
Market Cap: HK$11.7b
Produces and sells pharmaceutical products in Mainland China.
1681
HK$13.91
7D
-2.9%
1Y
n/a
Duality Biotherapeutics
Market Cap: HK$16.0b
A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$176.50
7D
-11.8%
1Y
n/a
Everest Medicines
Market Cap: HK$9.7b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$27.50
7D
-3.9%
1Y
-49.7%
Tong Ren Tang Technologies
Market Cap: HK$4.6b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$3.63
7D
2.5%
1Y
-29.9%